MLICM
TYRA icon

Metropolitan Life Insurance Company (MetLife)’s Tyra Biosciences TYRA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-814
Closed -$13.3K – 1979
2024
Q1 		$13.3K Hold
814
– – ﹤0.01% 2028
2023
Q4 		$11.3K Hold
814
– – ﹤0.01% 2143
2023
Q3 		$11.2K Hold
814
– – ﹤0.01% 2162
2023
Q2 		$13.9K Hold
814
– – ﹤0.01% 2121
2023
Q1 		$13.1K Buy
+814
New +$9.68K ﹤0.01% 2070

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TYRA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Tyra Biosciences (TYRA) in Q2 2024, closing a stake of 814 shares — an estimated $13.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TYRA in Q1 2023 and held it in 5 quarters. The position peaked at $13.9K in Q2 2023. 79 funds tracked by Wall St. Rank hold TYRA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Tyra Biosciences position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 814 Tyra Biosciences shares in Q2 2024, an estimated $13.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Tyra Biosciences in Q1 2023 and held it in 5 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Tyra Biosciences position peaked at $13.9K in Q2 2023.
  • 79 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.